Name Drotaverine hydrochloride solution Release form Solution MNNDrotaverine FTHS Spasmolytic agent What is the drug and what is it used for? The drug is an antispasmodic: the active substance drotaverine hydrochloride has a relaxing effect on smooth muscles. DROTAVERINA HYDROCHLORIDE is used: • for spasms of smooth muscles caused by diseases of the biliary tract; • with spasms of smooth muscles of the urinary tract; • to relieve spasm of smooth muscles caused by diseases of the stomach and intestines; • with painful menstruation. The use of the drug is contraindicated • in case of hypersensitivity to the active substance or to any of the excipients of the drug (see section Composition); • with severe diseases of the liver, kidneys or heart; • during childbirth and during breastfeeding; • in children and adolescents under 18 years of age. Special instructions and precautions Before using the drug, tell your doctor if you have low blood pressure. With intravenous administration of the drug, it is necessary to take a horizontal position. Children DROTAVERINE HYDROCHLORIDE is not used in children and adolescents under 18 years of age. DROTAVERINE HYDROCHLORIDE contains sodium metabisulphite. Sodium metabisulphite can occasionally cause hypersensitivity reactions and bronchospasm. DROTAVERINE HYDROCHLORIDE contains about 129 mg of ethanol per ampoule (2 ml), which is approximately equal to 3.44 ml of beer or 1.43 ml of wine. Should be considered in the case of pregnant women and high risk groups such as patients with liver disease, epilepsy, alcoholism. Other medicinesCheck with your doctor if you are taking, have recently taken or may start taking any other medicines. This also applies to any over-the-counter medications. Tell your doctor if you are taking levodopa. Drotaverine hydrochloride weakens the effect of levodopa, which alleviates the symptoms of Parkinson’s disease when used together, that is, the symptoms of the disease may worsen. Pregnancy, breast-feeding and fertility If you are pregnant or breast-feeding, think you may be pregnant or are planning to become pregnant, consult your doctor before taking this medicine. The decision to use the drug during pregnancy will be made by your doctor. The use of DROTAVERINE HYDROCHLORIDE during breastfeeding is not recommended. Driving and working with mechanisms During treatment, you should refrain from driving and working with moving mechanisms. Application of the drug The doctor will determine the dose of DROTAVERINE HYDROCHLORIDE that is suitable for you, the frequency of administration and the duration of treatment. The dose of the drug will depend on your general condition. DROTAVERINE HYDROCHLORIDE is used in the form of intramuscular injections and intravenous injections. Adults The average daily dose is 40-240 mg of drotaverine hydrochloride (divided into 1-3 injections per day) intramuscularly. In acute colic (biliary and urolithiasis) – 40-80 mg intravenously slowly. DROTAVERINE HYDROCHLORIDE is not used in children under 18 years of age. If you missed the next injection of the drug DROTAVERINE HYDROCHLORIDE If you miss the next injection of the drug, the next injection should be performed at a certain time. Do not double the dose to make up for the missed one. If you have taken more DROTAVERINE HYDROCHLORIDE than recommended If you think you have taken too much, tell your doctor or nurse. Overdose symptoms are associated with cardiac arrhythmia and cardiac conduction disturbances, which can be fatal. In case of overdose, seek medical attention immediately. If you have any doubts or questions, consult your doctor. Possible side effects Like all medicines, DROTAVERINE HYDROCHLORIDE can cause side effects, although not everyone gets them. In some cases, with the introduction of the drug, the development of severe allergic reactions is possible (there have been reports of cases of anaphylactic shock). Drotaverine hydrochloride may cause the following adverse reactions: rarely (may affect less than 1 in 1,000 people): • nausea; constipation; • dizziness; headache; insomnia; • cardiopalmus; lowering blood pressure; • allergic reactions, which may include rash, itching, urticaria, angioedema; • reactions at the injection site. Reporting Adverse Reactions If you experience any adverse reactions, talk to your doctor. This recommendation applies to any possible adverse reactions, including those not listed in the package insert. You can also report adverse reactions to the information database on adverse reactions (actions) to drugs, including reports of drug inefficiency (UE Center for Expertise and Testing in Healthcare, rceth.by). By reporting adverse reactions, you help to get more information about the safety of the drug. Storage of the drug Store in a place protected from light at a temperature not exceeding 25 ° C. Keep out of the reach and sight of children. Shelf life – 2 years. Do not use after the expiration date. Composition One ampoule contains the active substance: drotaverine hydrochloride – 40.0 mg; excipients: sodium metabisulfite E 223, rectified ethyl alcohol from food raw materials 95%, water for injection. Appearance of the drug and contents of the pack DROTAVERINE HYDROCHLORIDE, injection 20 mg/ml: clear yellow solution with a greenish tinge. 2 ml in ampoules. 5 ampoules are placed in a blister pack. 1 or 2 blister packs, together with a leaflet and an ampoule scarifier, are placed in a cardboard pack. When using ampoules with a break ring, it is allowed to pack ampoules without an ampoule scarifier. Leave conditions By prescription. Buy Drotaverine g/x solution d/in 20mg/ml amp 2ml cont ball pack No. 5×1 solution for injection 20mg/ml amp 2ml cont cell pack â„–5×1
Drotaverine g / x solution for injection 20mg / ml amp 2ml cont ball pack No. 5×1
$8.00
SKU: 2449
Category: Gastrointestinal tract
INN | DROTAVERIN |
---|---|
The code | 2 449 |
Barcode | 4 810 133 006 130 |
Dosage | 20mg/ml 2ml |
Active substance | Drotaverine |
Amount in a package | 60 |
Manufacturer | Belmedpreparaty RUE, Belarus |
Reviews
There are no reviews yet.